Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical: Archive
Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication
by Zacks Equity Research
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
ECLNegative Net Change BAXNegative Net Change DVANegative Net Change VEEVNegative Net Change
medical medical-devices
Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
by Zacks Equity Research
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
ECLNegative Net Change DVANegative Net Change VEEVNegative Net Change GKOSNegative Net Change
medical medical-devices
Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts
by Zacks Equity Research
Within Neuromodulation, Boston Scientific's pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.
BSXNegative Net Change RMDNegative Net Change HIMSPositive Net Change HITIPositive Net Change
medical
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
by Zacks Equity Research
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
BSXNegative Net Change ECLNegative Net Change PHGPositive Net Change ALGNPositive Net Change
medical medical-devices
Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
by Zacks Equity Research
Theravance's (TBPH) first-quarter 2024 earnings beat estimates while revenues meet the same.
TBPHNegative Net Change VTRSNegative Net Change THRDPositive Net Change
earnings medical
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
by Zacks Equity Research
QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.
RMDNegative Net Change QGENPositive Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
by Zacks Equity Research
Novo Nordisk's (NVO) shares rise 3.1% as the company meets co-primary endpoints in a late-stage study evaluating its investigational candidate, Mim8, for the treatment of haemophilia A.
NVONegative Net Change LGNDPositive Net Change ANIPNegative Net Change ANVSPositive Net Change
biotechnology biotechs medical pharmaceuticals
Company News For May 14, 2024
by Zacks Equity Research
Companies In The Article Are:SQSP,INCY, WBA and GOOG.
GOOGNegative Net Change INCYNegative Net Change WBAPositive Net Change SQSPNegative Net Change
computers medical retail
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
by Zacks Equity Research
Bayer's (BAYRY) Q1 earnings and sales decline year over year due to a fall in volumes for non-glyphosate-based herbicides and lower prices for glyphosate-based products in the Crop Science division.
REGNPositive Net Change JNJNegative Net Change BAYRYPositive Net Change LGNDPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals
Reasons to Add The Cooper Companies (COO) to Your Portfolio
by Zacks Equity Research
The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.
DVANegative Net Change ALGNPositive Net Change COOPositive Net Change MEDPPositive Net Change
medical medical-devices
Zacks.com featured highlights Medpace, American Axle, Diebold Nixdorf, Euronet and Omnicom
by Zacks Equity Research
Medpace, American Axle, Diebold Nixdorf, Euronet and Omnicom have been highlighted in this Screen of The Week article.
OMCPositive Net Change AXLPositive Net Change DBDPositive Net Change EEFTPositive Net Change MEDPPositive Net Change
medical
2 Intriguing Medical Stocks to Buy for Steady Growth as Earnings Approach
by Shaun Pruitt
Among the medical sector, Alcon (ALC) and Prestige Consumer Healthcare (PBH) are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.
ALCPositive Net Change PBHPositive Net Change
earnings investing medical
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
by Zacks Equity Research
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination vaccines. This announcement even overshadows the dismal Q1 results.
SNYNegative Net Change PFENegative Net Change MRNAPositive Net Change NVAXPositive Net Change
biotechs earnings medical vaccines
Top Analyst Reports for Boston Scientific, Arista Networks & Palo Alto Networks
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Boston Scientific Corporation (BSX), Arista Networks, Inc. (ANET) and Palo Alto Networks, Inc. (PANW).
BSXNegative Net Change AEPNegative Net Change CBOENegative Net Change HCAPositive Net Change PANWNegative Net Change ANETNegative Net Change
communications computers medical
QIAGEN (QGEN) to Enhance Forensics With New Partnership
by Zacks Equity Research
QIAGEN's (QGEN) recent deal advances a novel test for its QIAcuity digital PCR devices. This will enhance forensics by improving the quantification of DNA in human samples.
RMDNegative Net Change QGENPositive Net Change MEDPPositive Net Change EHCNegative Net Change
medical medical-devices
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
BSXNegative Net Change ECLNegative Net Change ISRGNegative Net Change ALGNPositive Net Change
medical medical-devices
Three Reasons to Retain Integer Holdings (ITGR) Stock for Now
by Zacks Equity Research
Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.
ECLNegative Net Change DVANegative Net Change VEEVNegative Net Change ITGRNegative Net Change
medical medical-devices
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials
by Zacks Equity Research
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
ECLNegative Net Change DVANegative Net Change VEEVNegative Net Change CTLTNegative Net Change
medical medical-devices
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
by Zacks Equity Research
Orthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to aid in curing fractures or abnormalities in individuals with osteogenesis imperfecta.
BSXNegative Net Change ECLNegative Net Change OFIXPositive Net Change ALGNPositive Net Change
medical medical-devices
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
by Zacks Equity Research
Bristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails to meet the primary endpoint of progression-free survival in unresectable stage III NSCLC.
AZNNegative Net Change BMYNegative Net Change MRKNegative Net Change LGNDPositive Net Change
biotechnology biotechs immuno-therapy medical oncology-screening pharmaceuticals
Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised
by Zacks Equity Research
Insulet's (PODD) first-quarter performance benefits from the continued high demand for Omnipod 5.
RMDNegative Net Change PODDPositive Net Change MEDPPositive Net Change EHCNegative Net Change
earnings medical
Company News For May 13, 2024
by Zacks Equity Research
Companies In The Article Are:NVAX, SNY, MRNA, G and IAG.
SNYNegative Net Change MRNAPositive Net Change GPositive Net Change NVAXPositive Net Change IAGPositive Net Change
business-services medical
U.S. Consumer Sentiment Plummets in May: 5 Safe Stock Picks
by Nalak Das
We have narrowed our search to five defensive stocks with strong potential for the rest of 2024. These are: ES, ATO, MKC, TSN, RMD.
RMDNegative Net Change TSNPositive Net Change MKCNegative Net Change ATOPositive Net Change ESNegative Net Change
consumer-staples medical utilities
Teleflex (TFX) Expands Vascular Access Portfolio With New Launch
by Zacks Equity Research
Teleflex (TFX) debuts the new Arrow EZ-IO Intraosseous Access Procedure Tray.
RMDNegative Net Change TFXPositive Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
5 Stocks With Upgraded Broker Ratings Worth Investing in Now
by Swayta Shah
Brokers have deeper insights into stocks and macroeconomic factors. So, one should follow broker rating upgrades to pick stocks like Medpace (MEDP), American Axle & Manufacturing (AXL), Diebold Nixdorf (DBD), Euronet (EEFT) and Omnicom (OMC).
OMCPositive Net Change AXLPositive Net Change DBDPositive Net Change EEFTPositive Net Change MEDPPositive Net Change
auto-tires-trucks business-services computers finance medical tech-stocks